News & Events

Publications

ISPOR 2026 (Conference)
FDA Approvals of Specialty Drugs, 2000-2024
A Survey of HEOR Leaders in Pharma on the Changing US Policy Landscape
A Survey of HEOR Leaders in Pharma about the State of HEOR
ISPOR 2026 (Conference Presentation)
Commercial payer coverage of biosimilars: 2017-2024
Health Affairs Scholar
Cost-Effectiveness Thresholds Used in the United States versus Most Favored Nations
Health Affairs Scholar
The timeliness of health plan drug coverage policy changes to FDA label revisions
Health Affairs Scholar
FDA approvals of specialty drugs, 2000-2024
JAMA Network Open
Drug Prices, Rebates, and Health Plan Coverage Restrictions
JMCP
Use of Clinical Outcome Assessments in Specialty Drug Coverage Policies